Enovis (ENOV) Tax Rate Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Enovis | 1.25 Bn | 1.22 Bn | 365.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 140,449.00 |
| Dec 31, 2025 | -3,453.00 |
| Oct 3, 2025 | -5,441.00 |
| Jul 4, 2025 | -13,264.00 |
| Apr 4, 2025 | -5,668.00 |
| Dec 31, 2024 | -4,631.00 |
| Sep 27, 2024 | 7,968.00 |
| Jun 28, 2024 | -4,066.00 |
| Mar 29, 2024 | 1,960.00 |
| Dec 31, 2023 | 28,743.00 |
| Sep 29, 2023 | -527.00 |
| Jun 30, 2023 | 5,350.00 |
| Mar 31, 2023 | 793.00 |
| Dec 31, 2022 | -209,330.00 |
| Sep 30, 2022 | -603.00 |
| Jul 1, 2022 | -3,565.00 |
| Apr 1, 2022 | -2,574.00 |
| Dec 31, 2021 | 1,979.00 |
| Oct 1, 2021 | 1,113.00 |
| Jul 2, 2021 | -2,341.00 |
| Apr 2, 2021 | -1,122.00 |
| Dec 31, 2020 | -1,499.00 |
| Oct 2, 2020 | 2,156.00 |
| Jul 3, 2020 | 6,200.00 |
| Apr 3, 2020 | 4,580.00 |
| Dec 31, 2019 | 3,039.00 |
| Sep 27, 2019 | -8,006.00 |
| Jun 28, 2019 | 21,498.00 |
| Mar 29, 2019 | -3,754.00 |
| Dec 31, 2018 | -26,849.00 |
| Sep 28, 2018 | 580.00 |
| Jun 29, 2018 | -5,731.00 |
| Mar 30, 2018 | -1,837.00 |
| Dec 31, 2017 | 2,105.00 |
| Sep 29, 2017 | -2,664.00 |
| Jun 30, 2017 | -1,406.00 |
| Mar 31, 2017 | 15,770.00 |
| Dec 31, 2016 | 9,915.00 |
| Sep 30, 2016 | 915.00 |
| Jul 1, 2016 | -16.00 |
| Apr 1, 2016 | 235.00 |
| Dec 31, 2015 | -410.00 |
| Sep 25, 2015 | 1,501.00 |
| Jun 26, 2015 | -641.00 |